logo
AAT Bioquest

Amplite® Fluorimetric α-Ketoglutarate Quantitation Kit

Alpha-ketoglutarate dose response was measured with the Amplite® Fluorimetric α-Ketoglutarate Quantitation Kit in a 96-well solid black plate using a Gemini fluorescence microplate reader (Molecular Devices) at Ex/Em = 540/590 nm, cutoff = 570 nm. As low as 1 µM of α-ketoglutarate can be detected with 30 minutes incubation.
Alpha-ketoglutarate dose response was measured with the Amplite® Fluorimetric α-Ketoglutarate Quantitation Kit in a 96-well solid black plate using a Gemini fluorescence microplate reader (Molecular Devices) at Ex/Em = 540/590 nm, cutoff = 570 nm. As low as 1 µM of α-ketoglutarate can be detected with 30 minutes incubation.
Alpha-ketoglutarate dose response was measured with the Amplite® Fluorimetric α-Ketoglutarate Quantitation Kit in a 96-well solid black plate using a Gemini fluorescence microplate reader (Molecular Devices) at Ex/Em = 540/590 nm, cutoff = 570 nm. As low as 1 µM of α-ketoglutarate can be detected with 30 minutes incubation.
Ordering information
Price
Catalog Number
Unit Size
Quantity
Add to cart
Additional ordering information
Telephone1-800-990-8053
Fax1-800-609-2943
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
ShippingStandard overnight for United States, inquire for international
Request quotation
Storage, safety and handling
H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
UNSPSC12171501

OverviewpdfSDSpdfProtocol


Alpha-ketoglutarate (α-ketoglutarate) is a key molecule in the Krebs cycle determining the overall rate of the citric acid cycle of the organism. As a precursor of glutamate and glutamine, α-ketoglutarate is a central metabolic fuel for cells of the gastrointestinal tract as well. It can decrease protein catabolism and increase protein synthesis to enhance bone tissue formation in the skeletal muscles and can be used in clinical applications. Alpha-ketoglutarate is used for kidney disease; intestinal and stomach disorders, including bacterial infections; liver problems; cataracts; and recurring yeast infections. It is also used for improving the way kidney patients receiving hemodialysis treatments process protein. Amplite®™ Fluorimetric α-Ketoglutarate Quantitation Kit offers a sensitive fluorimetric assay for quantifying α-ketoglutarate in biological samples. It utilizes an enzyme coupled reaction that releases hydrogen peroxide, which can be detected with Amplite®™ Red at Ex/Em ~540/590 nm (red fluorescence).

Platform


Fluorescence microplate reader

Excitation540 nm
Emission590 nm
Cutoff570 nm
Recommended plateSolid black

Components


Example protocol


AT A GLANCE

Protocol Summary
  1. Prepare α-Ketoglutarate standards or test samples (50 µL)
  2. Add α-Ketoglutarate Assay working solution (50 µL)
  3. Incubate at 37 °C for 30 to 60 minutes
  4. Read fluorescence intensity at Ex/Em = 540/590 nm 
Important      Thaw all the kit components to room temperature before starting the experiment.

PREPARATION OF STOCK SOLUTIONS

Unless otherwise noted, all unused stock solutions should be divided into single-use aliquots and stored at -20 °C after preparation. Avoid repeated freeze-thaw cycles.

Amplite™ Red stock solution (200X)
Add 50 µL of DMSO (Component E) into one vial of Amplite™ Red (Component A) and mix them well.
Note     Store unused Amplite™ Red stock solution (200X) at -20°C, avoid light and repeated freeze-thaw cycles.

PREPARATION OF STANDARD SOLUTION

For convenience, use the Serial Dilution Planner:
https://www.aatbio.com/tools/serial-dilution/10087


alpha-Ketoglutarate standard
Add 2.5 uL of alpha-Ketoglutarate standard in 225 uL of PBS buffer to make 100 uM. Perform 1:3 serial dilutions to get approximately 33, 11, 3.7, 1.23, 0.41 and 0.1 μM serially diluted α-ketoglutarate standards.

PREPARATION OF WORKING SOLUTION

α-Ketoglutarate Assay working solution
Add 5 mL Assay Buffer (Component C) into one Enzyme Mix 1 bottle (Component B1) and mix well. Add 100 μL of ddH2O into one Enzyme Mix 2 vial (Component B2) and mix well. Transfer entire vial (100 μL) of Enzyme Mix 2 and 25 µL of 200X Amplite™ Red stock solution (200X) into the vial of Enzyme Mix 1 and mix well.
Note     The 5 mL working solution is enough for one 96-wells plate. It is not stable, use it promptly.

SAMPLE EXPERIMENTAL PROTOCOL

Table 1. Layout of α-Ketoglutarate standards and test samples in a solid black 96-well microplate. AKG= α-Ketoglutarate Standards (AKG1 - AKG7, 0.1 to 100 µM), BL=Blank Control, TS=Test Samples.
BLBLTSTS
AKG1AKG1......
AKG2AKG2......
AKG3AKG3
AKG4AKG4
AKG5AKG5
AKG6AKG6
AKG7AKG7
Table 2. Reagent composition for each well.
WellVolumeReagent
AKG1 - AKG750 µLSerial Dilutions (0.1 to 100 µM)
BL50 µLAssay Buffer (Component C)
TS50 µLtest sample
  1. Prepare α-Ketoglutarate standards (AKG), blank controls (BL), and test samples (TS) according to the layout provided in Tables 1 and 2. For a 384-well plate, use 25 µL of reagent per well instead of 50 µL.
  2. Add 50 µL of α-Ketoglutarate Assay working solution to each well of α-Ketoglutarate standard, blank control, and test samples to make the total assay volume of 100 µL/well. For a 384-well plate, add 25 µL of α-Ketoglutarate working solution into each well instead, for a total volume of 50 µL/well.
  3. Incubate the reaction at 37 ºC for 30 - 60 minutes.
  4. Monitor the fluorescence increase with a fluorescence plate reader at Ex/Em = 540/590 nm (Cutoff = 570 nm). 

Images


Citations


View all 1 citations: Citation Explorer
Alpha-ketoglutarate alleviates cadmium-induced inflammation by inhibiting the HIF1A-TNFAIP3 pathway in hepatocytes
Authors: Jia, Yinzhao and Yin, Chuanzheng and Ke, Wenbo and Liu, Jing and Guo, Bing and Wang, Xiaofei and Zhao, Peng and Hu, Shaobo and Zhang, Chen and Li, Xuan and others,
Journal: Science of The Total Environment (2023): 163069

References


View all 40 references: Citation Explorer
Loss of Nardilysin, a Mitochondrial Co-chaperone for alpha-Ketoglutarate Dehydrogenase, Promotes mTORC1 Activation and Neurodegeneration
Authors: Yoon WH, S and oval H, Nagarkar-Jaiswal S, Jaiswal M, Yamamoto S, Haelterman NA, Putluri N, Putluri V, Sreekumar A, Tos T, Aksoy A, Donti T, Graham BH, Ohno M, Nishi E, Hunter J, Muzny DM, Carmichael J, Shen J, Arboleda VA, Nelson SF, Wangler MF, Karaca E, Lupski JR, Bellen HJ.
Journal: Neuron (2017): 115
Dietary alpha-ketoglutarate promotes higher protein and lower triacylglyceride levels and induces oxidative stress in larvae and young adults but not in middle-aged Drosophila melanogaster
Authors: Bayliak MM, Lylyk MP, Shmihel HV, Sorochynska OM, Semchyshyn OI, Storey JM, Storey KB, Lushchak VI.
Journal: Comp Biochem Physiol A Mol Integr Physiol (2017): 28
The facial triad in the alpha-ketoglutarate dependent oxygenase FIH: A role for sterics in linking substrate binding to O2 activation
Authors: Hangasky JA, Taabazuing CY, Martin CB, Eron SJ, Knapp MJ.
Journal: J Inorg Biochem (2017): 26
Comparative genomics analysis of a series of Yarrowia lipolytica WSH-Z06 mutants with varied capacity for alpha-ketoglutarate production
Authors: Zeng W, Fang F, Liu S, Du G, Chen J, Zhou J.
Journal: J Biotechnol (2016): 76
Applying pathway engineering to enhance production of alpha-ketoglutarate in Yarrowia lipolytica
Authors: Guo H, Su S, Madzak C, Zhou J, Chen H, Chen G.
Journal: Appl Microbiol Biotechnol (2016): 9875
Electronic Structure of the Ferryl Intermediate in the alpha-Ketoglutarate Dependent Non-Heme Iron Halogenase SyrB2: Contributions to H Atom Abstraction Reactivity
Authors: Srnec M, Wong SD, Matthews ML, Krebs C, Bollinger JM, Jr., Solomon EI.
Journal: J Am Chem Soc (2016): 5110
Registered report: The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate
Authors: Fiehn O, Showalter MR, Schaner-Tooley CE.
Journal: Elife (2016)
Reductions in the mitochondrial enzyme alpha-ketoglutarate dehydrogenase complex in neurodegenerative disease - beneficial or detrimental
Authors: Chen H, Denton TT, Xu H, Calingasan N, Beal MF, Gibson GE.
Journal: J Neurochem (2016): 823
Mild mitochondrial metabolic deficits by alpha-ketoglutarate dehydrogenase inhibition cause prominent changes in intracellular autophagic signaling: Potential role in the pathobiology of Alzheimer's disease
Authors: Banerjee K, Munshi S, Xu H, Frank DE, Chen HL, Chu CT, Yang J, Cho S, Kagan VE, Denton TT, Tyurina YY, Jiang JF, Gibson GE.
Journal: Neurochem Int (2016): 32
Mechanism of O2 Activation by alpha-Ketoglutarate Dependent Oxygenases Revisited. A Quantum Chemical Study
Authors: Wojcik A, Radon M, Borowski T.
Journal: J Phys Chem A (2016): 1261